These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9609356)

  • 1. Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes mellitus.
    Paolisso G; Howard BV
    Diabet Med; 1998 May; 15(5):360-6. PubMed ID: 9609356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiopathological fundamentals of type 2 diabetes].
    Girard J
    Rev Prat; 1999 Jan; 49(1):22-9. PubMed ID: 9926712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
    Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
    Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo metabolic defects in non-insulin-dependent diabetes mellitus.
    Bonadonna RC
    Horm Res; 1993; 39 Suppl 3():102-6. PubMed ID: 8262485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic fate of plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further early defects in the pathogenesis of type 2 diabetes.
    Bokhari S; Emerson P; Israelian Z; Gupta A; Meyer C
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E440-4. PubMed ID: 19141691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose sensing and the pathogenesis of obesity and type 2 diabetes.
    Thorens B
    Int J Obes (Lond); 2008 Dec; 32 Suppl 6():S62-71. PubMed ID: 19079282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes.
    Kishore P; Tonelli J; Koppaka S; Fratila C; Bose A; Lee DE; Reddy K; Hawkins M
    Diabetes; 2006 Jun; 55(6):1761-8. PubMed ID: 16731840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study.
    Charles MA; Eschwège E; Thibult N; Claude JR; Warnet JM; Rosselin GE; Girard J; Balkau B
    Diabetologia; 1997 Sep; 40(9):1101-6. PubMed ID: 9300248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.
    Boden G
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid metabolism in obesity and type 2 diabetes mellitus.
    Blaak EE
    Proc Nutr Soc; 2003 Aug; 62(3):753-60. PubMed ID: 14692611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma non-esterified fatty acid levels and insulin secretion in non-diabetic relatives of type 2 diabetic patients.
    Butler TJ; Barriocanal LA; Walker M
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):349-55. PubMed ID: 11589678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes.
    Cnop M
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):348-52. PubMed ID: 18481955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.